20-F 1 grfs-20231231x20f.htm FORM 20-F
0001438569--12-312023FYGrifols SA1.0014300000014300000085000000P2YP2Y1D0.50P5Dfalse0001438569grfs:StockOptionsSettledBy2027Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-12-310001438569grfs:StockOptionsSettledBy2025Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-12-310001438569grfs:IfrsRestrictedStockUnitsRsusMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMember2023-01-012023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMember2022-01-012022-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:BiotestAgMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:CustomerrelatedIntangibleAssetsMember2023-01-012023-12-310001438569grfs:BiotestAgMembergrfs:IfrsInProcessResearchAndDevelopmentMember2022-04-252022-04-250001438569grfs:BiotestAgMembergrfs:DistributionAgreementsMember2022-04-252022-04-250001438569grfs:BiotestAgMembergrfs:CurrentProductPortfolioMember2022-04-252022-04-250001438569ifrs-full:UnusedTaxLossesMember2022-12-310001438569grfs:IfrsRevolvingCreditFacilityMemberifrs-full:LiquidityRiskMember2023-12-310001438569grfs:IfrsRevolvingCreditFacilityMemberifrs-full:LiquidityRiskMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:NotLaterThanOneMonthMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanOneYearMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CurrentMember2023-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:CustomersWithObjectiveEvidenceOfImpairmentMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:NotLaterThanOneMonthMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanOneYearMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:CurrentMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMembergrfs:CustomersWithObjectiveEvidenceOfImpairmentMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:NotLaterThanOneMonthMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanOneYearMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CurrentMember2022-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:CustomersWithObjectiveEvidenceOfImpairmentMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:NotLaterThanOneMonthMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanOneYearMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:CurrentMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMembergrfs:CustomersWithObjectiveEvidenceOfImpairmentMember2022-12-310001438569grfs:ForeignCompaniesOtherThanSpanishCompaniesAndParentMember2023-12-310001438569grfs:ForeignCompaniesOtherThanSpanishCompaniesAndParentMember2022-12-310001438569ifrs-full:OrdinarySharesMemberifrs-full:TreasurySharesMember2023-12-310001438569grfs:OtherSegmentsMember2023-01-012023-12-310001438569grfs:OtherSegmentsMember2022-01-012022-12-310001438569grfs:OtherSegmentsMember2021-01-012021-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:TradeAndOtherPayablesToSuppliersMemberifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569grfs:TradeAndOtherPayablesToSuppliersMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:ReceivablesDueFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569grfs:ReceivablesDueFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:PayablesToGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569grfs:PayablesToGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:LoansReceivableFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569grfs:LoansReceivableFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:LoansPayableToGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:CashCashEquivalentsMemberifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569grfs:CashCashEquivalentsMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:BankLoansReceivedMemberifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:TradeAndOtherPayablesToSuppliersMemberifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569grfs:TradeAndOtherPayablesToSuppliersMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:ReceivablesDueFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569grfs:ReceivablesDueFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:PayablesToGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569grfs:PayablesToGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:LoansReceivableFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569grfs:LoansReceivableFromGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:LoansPayableToGroupCompaniesMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:CashCashEquivalentsMemberifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569grfs:CashCashEquivalentsMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:BankLoansReceivedMemberifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerEquipmentMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerEquipmentMember2023-12-310001438569ifrs-full:VehiclesMember2023-12-310001438569ifrs-full:MachineryMember2023-12-310001438569ifrs-full:LandAndBuildingsMember2023-12-310001438569ifrs-full:ComputerEquipmentMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerEquipmentMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerEquipmentMember2022-12-310001438569ifrs-full:VehiclesMember2022-12-310001438569ifrs-full:MachineryMember2022-12-310001438569ifrs-full:LandAndBuildingsMember2022-12-310001438569ifrs-full:ComputerEquipmentMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerEquipmentMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerEquipmentMember2021-12-310001438569grfs:UsaAndCanadaMember2023-01-012023-12-310001438569grfs:TransfusionalMedicineMember2023-01-012023-12-310001438569grfs:OthersProductMember2023-01-012023-12-310001438569grfs:OtherDiagnosticMember2023-01-012023-12-310001438569grfs:IfrsEuropeanUnionMember2023-01-012023-12-310001438569grfs:HaemoderivativesMember2023-01-012023-12-310001438569grfs:BioSuppliesProductMember2023-01-012023-12-310001438569country:ES2023-01-012023-12-310001438569grfs:UsaAndCanadaMember2022-01-012022-12-310001438569grfs:TransfusionalMedicineMember2022-01-012022-12-310001438569grfs:OthersProductMember2022-01-012022-12-310001438569grfs:OtherDiagnosticMember2022-01-012022-12-310001438569grfs:IfrsEuropeanUnionMember2022-01-012022-12-310001438569grfs:HaemoderivativesMember2022-01-012022-12-310001438569grfs:BioSuppliesProductMember2022-01-012022-12-310001438569country:ES2022-01-012022-12-310001438569grfs:UsaAndCanadaMember2021-01-012021-12-310001438569grfs:TransfusionalMedicineMember2021-01-012021-12-310001438569grfs:OthersProductMember2021-01-012021-12-310001438569grfs:OtherDiagnosticMember2021-01-012021-12-310001438569grfs:IfrsEuropeanUnionMember2021-01-012021-12-310001438569grfs:HaemoderivativesMember2021-01-012021-12-310001438569grfs:BioSuppliesProductMember2021-01-012021-12-310001438569country:ES2021-01-012021-12-310001438569grfs:TalecrisMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:TalecrisMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569grfs:GovernmentOfAndorraMembergrfs:GrifolsPyreneesResearchCenterSlMember2023-01-012023-12-310001438569grfs:HaemaagMember2022-01-012022-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Member2022-01-012022-12-310001438569grfs:BpcPlasmaIncMember2022-01-012022-12-310001438569grfs:BiotestAgMember2022-01-012022-12-310001438569grfs:GrifolsInnovationAndNewTechnologiesLimitedMember2023-10-092023-10-090001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2023-10-092023-10-090001438569grfs:GrifolsCanadaPlasmaInc.Member2023-07-072023-07-070001438569grfs:ClassSharesWithVotingRightsMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:ClassBSharesWithoutVotingRightsMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:GrifolsPyreneesResearchCenterSlMember2023-01-012023-12-310001438569grfs:GrifolsMalaysiaSdnBhdMember2023-01-012023-12-310001438569grfs:AccessBiologicalsLlcMember2022-06-152022-06-150001438569grfs:GigagenIncMember2021-03-082021-03-080001438569grfs:GrifolsInnovationAndNewTechnologiesLimitedMember2017-07-052017-07-050001438569grfs:BiodarourP.j.s.Co.Member2022-04-252022-04-250001438569grfs:NationalServiceProjectsOrganizationMembergrfs:GrifolsEgyptMember2021-07-292021-07-290001438569grfs:ImmunotekGhLlcMembergrfs:BiotekAmericaLlcMember2023-01-012023-12-310001438569grfs:ImmunotekGhLlcMembergrfs:BiotekAmericaLlcMember2021-07-012021-07-310001438569grfs:BiotekAmericaLlcMember2021-07-012021-07-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:ClassOrdinarySharesMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:ClassBOrdinarySharesMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticSolutionsInc.Member2023-01-012023-12-310001438569grfs:AlbajunaTherapeuticsS.lMember2023-01-012023-12-310001438569grfs:AlbajunaTherapeuticsS.lMember2022-01-012022-12-310001438569grfs:GrifolsEgyptPlasmaDerivativesMember2021-07-292021-07-290001438569grfs:MedcomAdvanceS.aMember2019-02-012019-02-280001438569grfs:MecwinsS.aMember2018-10-222018-10-220001438569grfs:AlbajunaTherapeuticsS.lMember2018-01-012018-12-310001438569grfs:GigaGenIncorporationMember2017-07-052017-07-050001438569grfs:AccessBiologicalsLLCMember2017-01-122017-01-120001438569grfs:AlbajunaTherapeuticsS.lMember2016-01-012016-12-310001438569grfs:AlbajunaTherapeuticsS.lMember2016-01-012016-12-310001438569grfs:AlbajunaTherapeuticsS.lMember2016-01-012016-01-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2023-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:PlantAndMachineryMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:PlantAndMachineryMember2023-12-310001438569ifrs-full:ConstructionInProgressMember2023-12-310001438569grfs:SelfConstructedPropertyPlantAndEquipmentMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2022-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:PlantAndMachineryMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:PlantAndMachineryMember2022-12-310001438569ifrs-full:ConstructionInProgressMember2022-12-310001438569grfs:SelfConstructedPropertyPlantAndEquipmentMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2021-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:PlantAndMachineryMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:PlantAndMachineryMember2021-12-310001438569grfs:GigaGenIncorporationMember2021-02-282021-02-280001438569ifrs-full:EliminationOfIntersegmentAmountsMember2023-01-012023-12-310001438569ifrs-full:EliminationOfIntersegmentAmountsMember2022-01-012022-12-310001438569ifrs-full:EliminationOfIntersegmentAmountsMember2021-01-012021-12-310001438569grfs:HaemaagMember2023-01-012023-12-310001438569grfs:BpcPlasmaIncMember2023-01-012023-12-310001438569grfs:HaemaagMember2022-01-012022-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Member2022-01-012022-12-310001438569grfs:BpcPlasmaIncMember2022-01-012022-12-310001438569grfs:BiotestAgMember2022-01-012022-12-310001438569ifrs-full:SubsidiariesWithMaterialNoncontrollingInterestsMember2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2023-01-012023-12-310001438569ifrs-full:SubsidiariesWithMaterialNoncontrollingInterestsMember2022-01-012022-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2022-01-012022-12-310001438569grfs:BiotekAmericaLlcMember2022-01-012022-12-310001438569grfs:AccessBiologicalLLCMember2023-12-310001438569grfs:BiotestAgMember2022-04-250001438569grfs:CustomerOneMembergrfs:BioscienceMember2023-01-012023-12-310001438569ifrs-full:GoodsSoldDirectlyToConsumersMember2023-01-012023-12-310001438569ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2023-01-012023-12-310001438569ifrs-full:GoodsSoldDirectlyToConsumersMember2022-01-012022-12-310001438569ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2022-01-012022-12-310001438569ifrs-full:GoodsSoldDirectlyToConsumersMember2021-01-012021-12-310001438569ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2021-01-012021-12-310001438569grfs:GrifolsPyreneesResearchCenterSlMember2022-01-012022-12-310001438569ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2022-12-310001438569ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2022-12-310001438569ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2022-12-310001438569ifrs-full:PreferenceSharesMember2021-12-310001438569ifrs-full:OrdinarySharesMember2021-12-310001438569ifrs-full:OrdinarySharesMember2022-12-310001438569grfs:StockOptionsSettledBy2027Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:StockOptionsSettledBy2025Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:RestrictedStockUnitsSettledBy28022025Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:RestrictedStockUnitsSettledBy28022024Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:RestrictedStockUnitsSettledBy22022025Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:RestrictedStockUnitsSettledBy2027Membergrfs:CashSettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:RestrictedStockUnitsSettledBy2025Membergrfs:CashSettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:NotLaterThanOneYearMembercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:NotLaterThanOneYearMembercurrency:EUR2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembercurrency:EUR2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembercurrency:EUR2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Memberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembercurrency:EUR2023-12-310001438569grfs:SeniorDebtWithTwoTermFacilitiesDue2024Member2023-12-310001438569grfs:RevolvingCreditFacilityDue2024Member2023-12-310001438569ifrs-full:CurrencySwapContractMember2021-10-050001438569grfs:SeniorDebtTrancheBDue2027Membercurrency:USD2019-11-190001438569grfs:SeniorDebtTrancheBDue2027Membercurrency:EUR2019-11-190001438569grfs:EuropeanInvestmentBankLongTermLoansOfEurosTwoMember2018-12-310001438569grfs:EuropeanInvestmentBankLongTermLoansOfEurosThreeMember2018-12-310001438569grfs:EuropeanInvestmentBankLongTermLoansOfEurosOneMember2018-12-310001438569grfs:EIBLoanMember2018-12-310001438569grfs:HaemaagMember2023-12-310001438569grfs:BpcPlasmaIncMember2023-12-310001438569grfs:HaemaagMember2022-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Member2022-12-310001438569grfs:BpcPlasmaIncMember2022-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:IntangibleAssetsOtherThanGoodwillMember2023-12-310001438569ifrs-full:LiabilitiesMembergrfs:FixedAssetsMember2023-12-310001438569ifrs-full:LiabilitiesMembergrfs:DebtCancellationCostsMember2023-12-310001438569ifrs-full:ClassesOfAssetsMembergrfs:UnusedTaxCreditsDeductionsMember2023-12-310001438569ifrs-full:LiabilitiesMembergrfs:FixedAssetsMember2022-12-310001438569ifrs-full:LiabilitiesMembergrfs:DebtCancellationCostsMember2022-12-310001438569ifrs-full:ClassesOfAssetsMembergrfs:UnusedTaxCreditsDeductionsMember2022-12-310001438569ifrs-full:LiabilitiesMembergrfs:FixedAssetsMember2021-12-310001438569ifrs-full:LiabilitiesMembergrfs:DebtCancellationCostsMember2021-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:PropertyPlantAndEquipmentMember2023-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:OtherTemporaryDifferencesMember2023-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:GoodwillMember2023-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:UnusedTaxLossesMember2023-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:UnusedTaxCreditsMember2023-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:PropertyPlantAndEquipmentMember2023-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:OtherTemporaryDifferencesMember2023-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:OtherProvisionsMember2023-12-310001438569ifrs-full:ClassesOfAssetsMembergrfs:IfrsInventoriesMember2023-12-310001438569ifrs-full:LiabilitiesMember2023-12-310001438569ifrs-full:ClassesOfAssetsMember2023-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:PropertyPlantAndEquipmentMember2022-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:OtherTemporaryDifferencesMember2022-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:IntangibleAssetsOtherThanGoodwillMember2022-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:GoodwillMember2022-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:UnusedTaxLossesMember2022-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:UnusedTaxCreditsMember2022-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:OtherTemporaryDifferencesMember2022-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:OtherProvisionsMember2022-12-310001438569ifrs-full:ClassesOfAssetsMembergrfs:IfrsInventoriesMember2022-12-310001438569ifrs-full:LiabilitiesMember2022-12-310001438569ifrs-full:ClassesOfAssetsMember2022-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:PropertyPlantAndEquipmentMember2021-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:IntangibleAssetsOtherThanGoodwillMember2021-12-310001438569ifrs-full:LiabilitiesMemberifrs-full:GoodwillMember2021-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:UnusedTaxLossesMember2021-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:UnusedTaxCreditsMember2021-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:OtherTemporaryDifferencesMember2021-12-310001438569ifrs-full:ClassesOfAssetsMemberifrs-full:OtherProvisionsMember2021-12-310001438569ifrs-full:ClassesOfAssetsMembergrfs:IfrsInventoriesMember2021-12-310001438569ifrs-full:LiabilitiesMember2021-12-310001438569ifrs-full:ClassesOfAssetsMember2021-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMemberifrs-full:CountryOfDomicileMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:OtherGeographicRegionsMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:OtherEuropeanCountriesMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:EuropeanUnionExcludingSpainMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembercountry:US2023-12-310001438569ifrs-full:TradeReceivablesMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMember2023-12-310001438569grfs:OtherReceivablesIncludingAdvancesMember2023-12-310001438569grfs:OtherCurrentFinancialAssetsMember2023-12-310001438569grfs:NonCurrentFinancialAssetsMember2023-12-310001438569grfs:ContractualAssetsMember2023-12-310001438569grfs:CashCashEquivalentsMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMemberifrs-full:CountryOfDomicileMember2022-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:OtherGeographicRegionsMember2022-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:OtherEuropeanCountriesMember2022-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:EuropeanUnionExcludingSpainMember2022-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembercountry:US2022-12-310001438569ifrs-full:TradeReceivablesMember2022-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMember2022-12-310001438569grfs:OtherReceivablesIncludingAdvancesMember2022-12-310001438569grfs:OtherCurrentFinancialAssetsMember2022-12-310001438569grfs:NonCurrentFinancialAssetsMember2022-12-310001438569grfs:ContractualAssetsMember2022-12-310001438569grfs:CashCashEquivalentsMember2022-12-310001438569grfs:SeniorDebtDue2024Member2022-12-310001438569ifrs-full:CurrencySwapContractMemberifrs-full:CashFlowHedgesMembercurrency:USD2021-10-050001438569ifrs-full:PresentValueOfDefinedBenefitObligationMember2023-12-310001438569ifrs-full:PlanAssetsMember2023-12-310001438569ifrs-full:PresentValueOfDefinedBenefitObligationMember2022-12-310001438569ifrs-full:PlanAssetsMember2022-12-310001438569ifrs-full:PresentValueOfDefinedBenefitObligationMember2021-12-310001438569ifrs-full:PlanAssetsMember2021-12-310001438569grfs:CashSettledShareBasedPaymentPlanMember2023-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2023-12-310001438569grfs:OtherFinancialLiabilitiesMember2023-12-310001438569grfs:IfrsBondsMember2023-12-310001438569grfs:FinanceLeaseLiabilitiesMember2023-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2022-12-310001438569grfs:OtherFinancialLiabilitiesMember2022-12-310001438569grfs:IfrsBondsMember2022-12-310001438569grfs:FinanceLeaseLiabilitiesMember2022-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2021-12-310001438569grfs:OtherFinancialLiabilitiesMember2021-12-310001438569grfs:IfrsBondsMember2021-12-310001438569grfs:FinanceLeaseLiabilitiesMember2021-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2020-12-310001438569grfs:OtherFinancialLiabilitiesMember2020-12-310001438569grfs:IfrsBondsMember2020-12-310001438569grfs:FinanceLeaseLiabilitiesMember2020-12-310001438569grfs:IFRSIPOMember2006-05-172006-05-170001438569grfs:GrifolsEgyptPlasmaDerivativesMember2021-07-290001438569grfs:AlbajunaTherapeuticsS.lMember2016-12-310001438569grfs:TotalOfRestOfEquityAccountedInvesteesMember2023-12-310001438569grfs:TotalEquityAccountedInvesteesWithSimilarActivityToThatOfGroupMember2023-12-310001438569grfs:MecwinsS.aMember2023-12-310001438569grfs:GrifolsEgyptPlasmaDerivativesMember2023-12-310001438569grfs:BiodarourP.j.s.Co.Member2023-12-310001438569grfs:TotalOfRestOfEquityAccountedInvesteesMember2022-12-310001438569grfs:TotalEquityAccountedInvesteesWithSimilarActivityToThatOfGroupMember2022-12-310001438569grfs:MecwinsS.aMember2022-12-310001438569grfs:GrifolsEgyptPlasmaDerivativesMember2022-12-310001438569grfs:BiodarourP.j.s.Co.Member2022-12-310001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2022-12-310001438569grfs:TotalOfRestOfEquityAccountedInvesteesMember2021-12-310001438569grfs:TotalEquityAccountedInvesteesWithSimilarActivityToThatOfGroupMember2021-12-310001438569grfs:PlasmavitaHealthcareMember2021-12-310001438569grfs:MecwinsS.aMember2021-12-310001438569grfs:GrifolsEgyptPlasmaDerivativesMember2021-12-310001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2021-12-310001438569grfs:TotalOfRestOfEquityAccountedInvesteesMember2020-12-310001438569grfs:TotalEquityAccountedInvesteesWithSimilarActivityToThatOfGroupMember2020-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2020-12-310001438569grfs:MecwinsS.aMember2020-12-310001438569grfs:GigaGenIncorporationMember2020-12-310001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2020-12-310001438569grfs:AccessBiologicalsLlcMember2020-12-310001438569ifrs-full:AccumulatedImpairmentMember2021-12-310001438569ifrs-full:AccumulatedImpairmentMember2020-12-310001438569grfs:TalecrisMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:TalecrisMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:BiotestAgMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:BiotestAgMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2023-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CustomerrelatedIntangibleAssetsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CapitalisedDevelopmentExpenditureMember2023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:OtherIntangibleAssetsMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherIntangibleAssetsMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CapitalisedDevelopmentExpenditureMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-12-310001438569grfs:BiotestAgMembergrfs:CapitalisedDevelopmentCostsInProgressMember2023-12-310001438569grfs:AlkahestIncMembergrfs:CapitalisedDevelopmentCostsInProgressMember2023-12-310001438569ifrs-full:InternallyGeneratedMember2023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001438569grfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2023-12-310001438569grfs:CapitalisedDevelopmentCostsInProgressMember2023-12-310001438569grfs:TalecrisMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:TalecrisMemberifrs-full:GrossCarryingAmountMembergrfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2022-12-310001438569grfs:TalecrisMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:TalecrisMemberifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2022-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:GrossCarryingAmountMembergrfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2022-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2022-12-310001438569grfs:BiotestAgMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:BiotestAgMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2022-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CustomerrelatedIntangibleAssetsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CapitalisedDevelopmentExpenditureMember2022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:OtherIntangibleAssetsMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherIntangibleAssetsMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CapitalisedDevelopmentExpenditureMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-12-310001438569grfs:BiotestAgMembergrfs:CapitalisedDevelopmentCostsInProgressMember2022-12-310001438569grfs:AlkahestIncMembergrfs:CapitalisedDevelopmentCostsInProgressMember2022-12-310001438569ifrs-full:InternallyGeneratedMember2022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001438569grfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2022-12-310001438569grfs:CapitalisedDevelopmentCostsInProgressMember2022-12-310001438569grfs:TalecrisMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2021-12-310001438569grfs:TalecrisMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2021-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2021-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CapitalisedDevelopmentExpenditureMember2021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2021-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:OtherIntangibleAssetsMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherIntangibleAssetsMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CapitalisedDevelopmentExpenditureMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2021-12-310001438569ifrs-full:GrossCarryingAmountMember2021-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001438569grfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2021-12-310001438569grfs:TalecrisMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:TalecrisMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569grfs:GrifolsUkLtdMember2023-01-012023-12-310001438569grfs:GrifolsTherapeuticsIncMember2023-01-012023-12-310001438569grfs:GrifolsDiagnosticNovartisMember2023-01-012023-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2023-01-012023-12-310001438569grfs:GrifolsAustraliaPtyLtdAndMedionDiagnosticsAgMember2023-01-012023-12-310001438569grfs:GigagenIncVerNota3Member2023-01-012023-12-310001438569grfs:BpcPlasmaInc.Member2023-01-012023-12-310001438569grfs:BiomatUsaIncMember2023-01-012023-12-310001438569grfs:AlkahestIncorporatedMember2023-01-012023-12-310001438569grfs:GrifolsUkLtdMember2022-01-012022-12-310001438569grfs:GrifolsTherapeuticsIncMember2022-01-012022-12-310001438569grfs:GrifolsDiagnosticNovartisMember2022-01-012022-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2022-01-012022-12-310001438569grfs:GrifolsAustraliaPtyLtdAndMedionDiagnosticsAgMember2022-01-012022-12-310001438569grfs:GigagenIncVerNota3Member2022-01-012022-12-310001438569grfs:BpcPlasmaInc.Member2022-01-012022-12-310001438569grfs:AlkahestIncorporatedMember2022-01-012022-12-310001438569ifrs-full:PreferenceSharesMember2023-01-012023-12-310001438569ifrs-full:PreferenceSharesMember2022-01-012022-12-310001438569ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember2023-12-310001438569ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember2022-12-310001438569ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember2023-12-310001438569ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember2023-12-310001438569grfs:ActuarialAssumptionOfRateOfInterestMember2023-12-310001438569ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember2022-12-310001438569ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember2022-12-310001438569grfs:ActuarialAssumptionOfRateOfInterestMember2022-12-310001438569ifrs-full:NotLaterThanOneYearMember2022-12-310001438569grfs:GoetechLlc.AcquisitionMember2022-01-012022-12-310001438569grfs:ProgenikaBiopharmaSaMember2023-12-310001438569grfs:PlasmavitaHealthcareGmbhMember2023-12-310001438569grfs:KiroGrifolsS.lMember2023-12-310001438569grfs:HaemaPlasmaKftMember2023-12-310001438569grfs:HaemaAgMember2023-12-310001438569grfs:GrifolsUkLtdMember2023-12-310001438569grfs:GrifolsTherapeuticsIncMember2023-12-310001438569grfs:GrifolsItaliaS.p.a.Member2023-12-310001438569grfs:GrifolsDiagnosticNovartisMember2023-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2023-12-310001438569grfs:GrifolsCanadaPlasmaIncMember2023-12-310001438569grfs:GrifolsBiotestHoldingsGmbhBiotestAgMember2023-12-310001438569grfs:GrifolsBioSuppliesIncMember2023-12-310001438569grfs:GrifolsAustraliaPtyLtdAndMedionDiagnosticsAgMember2023-12-310001438569grfs:GigagenIncVerNota3Member2023-12-310001438569grfs:BpcPlasmaInc.Member2023-12-310001438569grfs:BiomatUsaIncMember2023-12-310001438569grfs:AlkahestIncorporatedMember2023-12-310001438569grfs:ProgenikaBiopharmaSaMember2022-12-310001438569grfs:PlasmavitaHealthcareGmbhMember2022-12-310001438569grfs:KiroGrifolsS.lMember2022-12-310001438569grfs:HaemaPlasmaKftMember2022-12-310001438569grfs:HaemaAgMember2022-12-310001438569grfs:GrifolsUkLtdMember2022-12-310001438569grfs:GrifolsTherapeuticsIncMember2022-12-310001438569grfs:GrifolsItaliaS.p.a.Member2022-12-310001438569grfs:GrifolsDiagnosticNovartisMember2022-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2022-12-310001438569grfs:GrifolsCanadaPlasmaIncMember2022-12-310001438569grfs:GrifolsBiotestHoldingsGmbhBiotestAgMember2022-12-310001438569grfs:GrifolsAustraliaPtyLtdAndMedionDiagnosticsAgMember2022-12-310001438569grfs:GigagenIncVerNota3Member2022-12-310001438569grfs:BpcPlasmaInc.Member2022-12-310001438569grfs:BiomatUsaIncMember2022-12-310001438569grfs:AlkahestIncorporatedMember2022-12-310001438569grfs:AccessBiologicalsLLCMember2022-12-310001438569grfs:ProgenikaBiopharmaSaMember2021-12-310001438569grfs:PlasmavitaHealthcareGmbhMember2021-12-310001438569grfs:KiroGrifolsS.lMember2021-12-310001438569grfs:InterstateBloodBankIncorporationMember2021-12-310001438569grfs:HaemaAgMember2021-12-310001438569grfs:GrifolsUkLtdMember2021-12-310001438569grfs:GrifolsTherapeuticsIncMember2021-12-310001438569grfs:GrifolsItaliaS.p.a.Member2021-12-310001438569grfs:GrifolsDiagnosticNovartisMember2021-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2021-12-310001438569grfs:GrifolsAustraliaPtyLtdAndMedionDiagnosticsAgMember2021-12-310001438569grfs:GoetechLlc.AcquisitionMember2021-12-310001438569grfs:GigagenIncVerNota3Member2021-12-310001438569grfs:BpcPlasmaInc.Member2021-12-310001438569grfs:BiomatUsaIncMember2021-12-310001438569grfs:AlkahestIncorporatedMember2021-12-310001438569grfs:GoetechLlcMember2022-07-012022-07-310001438569grfs:VcnBioscienceS.lMember2022-03-102022-03-100001438569grfs:VcnBioscienceS.lMember2022-03-102022-03-100001438569grfs:GigaGenIncorporationMember2021-03-082021-03-080001438569grfs:SeniorUnsecuredAndSecuredNotesMemberifrs-full:Level1OfFairValueHierarchyMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:SeniorSecuredBankLoansMemberifrs-full:Level2OfFairValueHierarchyMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:SeniorUnsecuredAndSecuredNotesMemberifrs-full:Level1OfFairValueHierarchyMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:SeniorSecuredBankLoansMemberifrs-full:Level2OfFairValueHierarchyMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembergrfs:OtherCurrentLiabilitiesExcludingSalariesPayableMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberifrs-full:LeaseLiabilitiesMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:TradeAndOtherPayablesToSuppliersMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:SeniorUnsecuredAndSecuredNotesMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:SeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:PromissoryNotesMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:OtherFinancialLiabilitiesMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:OtherBankLoansExcludingSeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:DerivativesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:LeaseLiabilitiesMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:TradeAndOtherPayablesToSuppliersMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:SeniorUnsecuredAndSecuredNotesMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:SeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:PromissoryNotesMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:OtherFinancialLiabilitiesMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:OtherCurrentLiabilitiesExcludingSalariesPayableMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:OtherBankLoansExcludingSeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:InterestRateRiskMember2023-12-310001438569ifrs-full:FloatingInterestRateMember2023-12-310001438569ifrs-full:FixedInterestRateMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembergrfs:OtherNonCurrentDebtsMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembergrfs:OtherCurrentLiabilitiesExcludingSalariesPayableMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberifrs-full:LeaseLiabilitiesMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:TradeAndOtherPayablesToSuppliersMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:SeniorUnsecuredAndSecuredNotesMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:SeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:PromissoryNotesMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:OtherFinancialLiabilitiesMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:OtherBankLoansExcludingSeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:DerivativesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:LeaseLiabilitiesMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:TradeAndOtherPayablesToSuppliersMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:SeniorUnsecuredAndSecuredNotesMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:SeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:PromissoryNotesMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:OtherNonCurrentDebtsMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:OtherFinancialLiabilitiesMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:OtherCurrentLiabilitiesExcludingSalariesPayableMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:OtherBankLoansExcludingSeniorSecuredBankLoansMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:InterestRateRiskMember2022-12-310001438569ifrs-full:FloatingInterestRateMember2022-12-310001438569ifrs-full:FixedInterestRateMember2022-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:DerivativesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:AtFairValueMember2023-12-310001438569grfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:AtFairValueMember2023-12-310001438569grfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:DerivativesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:AtFairValueMember2022-12-310001438569grfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:Level3OfFairValueHierarchyMemberifrs-full:AtFairValueMember2022-12-310001438569grfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:Level1OfFairValueHierarchyMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembergrfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:TradeReceivablesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMembergrfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:OtherCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:NonCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:CashCashEquivalentsMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:DerivativesDesignatedAsHedgingInstrumentsCategoryMemberifrs-full:DerivativesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:DerivativesMemberifrs-full:AtFairValueMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2023-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:OtherCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:NonCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2023-12-310001438569grfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:AtFairValueMember2023-12-310001438569grfs:DerivativesDesignatedAsHedgingInstrumentsCategoryMemberifrs-full:AtFairValueMember2023-12-310001438569grfs:CashCashEquivalentsMembergrfs:NotAtFairValueMember2023-12-310001438569ifrs-full:AtFairValueMember2023-12-310001438569grfs:NotAtFairValueMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembergrfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:TradeReceivablesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMembergrfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:OtherCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:NonCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:CashCashEquivalentsMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:DerivativesDesignatedAsHedgingInstrumentsCategoryMemberifrs-full:DerivativesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:TradeReceivablesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:DerivativesMemberifrs-full:AtFairValueMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2022-12-310001438569grfs:TradeAndOtherReceivablesIncludingAdvancesMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:OtherCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:NonCurrentFinancialAssetsMembergrfs:NotAtFairValueMember2022-12-310001438569grfs:NonCurrentFinancialAssetsExcludingDerivativesMemberifrs-full:AtFairValueMember2022-12-310001438569grfs:DerivativesDesignatedAsHedgingInstrumentsCategoryMemberifrs-full:AtFairValueMember2022-12-310001438569grfs:CashCashEquivalentsMembergrfs:NotAtFairValueMember2022-12-310001438569ifrs-full:AtFairValueMember2022-12-310001438569grfs:NotAtFairValueMember2022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2021-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2020-12-310001438569ifrs-full:DerivativesMember2023-01-012023-12-310001438569ifrs-full:DerivativesMember2022-01-012022-12-310001438569grfs:WagesAndSalariesMember2023-01-012023-12-310001438569grfs:ProfessionalServicesMember2023-01-012023-12-310001438569grfs:EquitySettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569grfs:RestrictedShareUnitRetentionPlanMember2022-01-012022-12-310001438569grfs:CashSettledShareBasedPaymentPlanMember2023-01-012023-12-310001438569ifrs-full:NotLaterThanOneMonthMember2023-12-310001438569ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2023-12-310001438569ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2023-12-310001438569ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2023-12-310001438569ifrs-full:LaterThanOneYearMember2023-12-310001438569ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2023-12-310001438569ifrs-full:CurrentMember2023-12-310001438569ifrs-full:NotLaterThanOneMonthMember2022-12-310001438569ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2022-12-310001438569ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2022-12-310001438569ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2022-12-310001438569ifrs-full:LaterThanOneYearMember2022-12-310001438569ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2022-12-310001438569ifrs-full:CurrentMember2022-12-310001438569grfs:RamirezVivarAlfonsoV.GrifolsDiagnosticSolutionsIncMember2022-11-040001438569ifrs-full:LegalProceedingsContingentLiabilityMembergrfs:AbbottVsPartiesPatentInfringementDisputeMember2020-06-160001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:PlasmavitaHealthcareMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:KiroGrifolsLimitedLiabilityCompanyMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:HaemaPlasmaKftMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:HaemaAgMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsThailandLtdMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsPyreneesResearchCenterSlMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsMalaysiaSdnBhdMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsDiagnosticSolutionsInc.Member2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:BpcPlasmaIncMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:BiotestAgMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:AraclonBiotechS.A.MemberRaclonBiotechS.a.Member2023-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:AlbimmuneS.l.Member2023-12-310001438569ifrs-full:TreasurySharesMember2023-12-310001438569ifrs-full:SharePremiumMember2023-12-310001438569ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2023-12-310001438569ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2023-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-12-310001438569ifrs-full:ReserveOfCashFlowHedgesMember2023-12-310001438569ifrs-full:NoncontrollingInterestsMember2023-12-310001438569ifrs-full:IssuedCapitalMember2023-12-310001438569ifrs-full:EquityAttributableToOwnersOfParentMember2023-12-310001438569ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember2023-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2023-12-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMember2022-12-310001438569ifrs-full:OrdinarySharesMemberifrs-full:TreasurySharesMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:PlasmavitaHealthcareMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:KiroGrifolsLimitedLiabilityCompanyMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:HaemaPlasmaKftMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:HaemaAgMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsThailandLtdMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsPyreneesResearchCenterSlMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsMalaysiaSdnBhdMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsDiagnosticSolutionsInc.Member2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:DiagnosticsSolutionsInc.Member2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:BpcPlasmaIncMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:BiotestAgMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:AraclonBiotechS.A.MemberRaclonBiotechS.a.Member2022-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:AlbimmuneS.l.Member2022-12-310001438569ifrs-full:TreasurySharesMember2022-12-310001438569ifrs-full:SharePremiumMember2022-12-310001438569ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2022-12-310001438569ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2022-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-12-310001438569ifrs-full:ReserveOfCashFlowHedgesMember2022-12-310001438569ifrs-full:NoncontrollingInterestsMember2022-12-310001438569ifrs-full:IssuedCapitalMember2022-12-310001438569ifrs-full:EquityAttributableToOwnersOfParentMember2022-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2022-12-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:VcnBioscienceSlMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:PlasmavitaHealthcareMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:KiroGrifolsLimitedLiabilityCompanyMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:HaemaAgMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsThailandLtdMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:GrifolsMalaysiaSdnBhdMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:DiagnosticsSolutionsInc.Member2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:BpcPlasmaIncMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMembergrfs:AraclonBiotechS.A.MemberRaclonBiotechS.a.Member2021-12-310001438569ifrs-full:TreasurySharesMember2021-12-310001438569ifrs-full:SharePremiumMember2021-12-310001438569ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2021-12-310001438569ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2021-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001438569ifrs-full:ReserveOfCashFlowHedgesMember2021-12-310001438569ifrs-full:NoncontrollingInterestsMember2021-12-310001438569ifrs-full:IssuedCapitalMember2021-12-310001438569ifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2021-12-310001438569ifrs-full:TreasurySharesMember2020-12-310001438569ifrs-full:SharePremiumMember2020-12-310001438569ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2020-12-310001438569ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2020-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001438569ifrs-full:NoncontrollingInterestsMember2020-12-310001438569ifrs-full:IssuedCapitalMember2020-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2020-12-310001438569grfs:BpcPlasmaIncMembergrfs:ScrantonPlasmaBVMember2023-01-012023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:OtherIntangibleAssetsMember2023-01-012023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:OtherIntangibleAssetsMember2022-01-012022-12-310001438569grfs:KiroGrifolsMember2023-12-310001438569grfs:GigaGenIncorporationMember2023-12-310001438569grfs:DiagnosticMember2023-12-310001438569grfs:BioSuppliesMember2023-12-310001438569grfs:BiopharmaMember2023-12-310001438569grfs:KiroGrifolsMember2022-12-310001438569grfs:GigaGenIncorporationMember2022-12-310001438569grfs:DiagnosticMember2022-12-310001438569grfs:BioSuppliesMember2022-12-310001438569grfs:BiopharmaMember2022-12-310001438569grfs:AccessBiologicalsLLCMemberifrs-full:CustomerrelatedIntangibleAssetsMember2022-06-150001438569grfs:BiotestAgMemberifrs-full:TopOfRangeMember2022-04-250001438569grfs:BiotestAgMemberifrs-full:BottomOfRangeMember2022-04-250001438569ifrs-full:VehiclesMember2023-01-012023-12-310001438569ifrs-full:MachineryMember2023-01-012023-12-310001438569ifrs-full:ComputerEquipmentMember2023-01-012023-12-310001438569ifrs-full:BuildingsMember2023-01-012023-12-310001438569ifrs-full:VehiclesMember2022-01-012022-12-310001438569ifrs-full:MachineryMember2022-01-012022-12-310001438569ifrs-full:ComputerEquipmentMember2022-01-012022-12-310001438569ifrs-full:BuildingsMember2022-01-012022-12-310001438569ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:TopOfRangeMember2023-01-012023-12-310001438569ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:BottomOfRangeMember2023-01-012023-12-310001438569ifrs-full:BuildingsMemberifrs-full:TopOfRangeMember2023-01-012023-12-310001438569ifrs-full:BuildingsMemberifrs-full:BottomOfRangeMember2023-01-012023-12-310001438569grfs:OtherPropertyTechnicalEquipmentAndMachineryMemberifrs-full:TopOfRangeMember2023-01-012023-12-310001438569grfs:OtherPropertyTechnicalEquipmentAndMachineryMemberifrs-full:BottomOfRangeMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2022-01-012022-12-310001438569ifrs-full:SellingGeneralAndAdministrativeExpenseMember2023-01-012023-12-310001438569ifrs-full:CostOfSalesMember2023-01-012023-12-310001438569grfs:ResearchAndDevelopmentMember2023-01-012023-12-310001438569ifrs-full:SellingGeneralAndAdministrativeExpenseMember2022-01-012022-12-310001438569ifrs-full:CostOfSalesMember2022-01-012022-12-310001438569grfs:ResearchAndDevelopmentMember2022-01-012022-12-310001438569ifrs-full:SellingGeneralAndAdministrativeExpenseMember2021-01-012021-12-310001438569ifrs-full:CostOfSalesMember2021-01-012021-12-310001438569grfs:ResearchAndDevelopmentMember2021-01-012021-12-310001438569grfs:DefinedBenefitPlansOtherThanPensionPlansMember2023-12-310001438569grfs:DefinedBenefitPlansOtherThanPensionPlansMember2022-12-310001438569ifrs-full:UnusedTaxLossesMember2023-12-310001438569grfs:UnusedTaxLossesThatWillBeRecoveredInLessThanFiveYearsMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2023-01-012023-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2022-01-012022-12-310001438569ifrs-full:AccumulatedImpairmentMemberifrs-full:TradeReceivablesMember2021-01-012021-12-310001438569ifrs-full:AccumulatedImpairmentMember2023-12-310001438569ifrs-full:AccumulatedImpairmentMember2022-12-310001438569grfs:SeniorDebtDue2024Member2023-12-310001438569grfs:HaemaagMembergrfs:HaemaagMember2023-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Membergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-12-310001438569grfs:BpcPlasmaIncMembergrfs:BpcPlasmaIncMember2023-12-310001438569grfs:BiotestAgMembergrfs:BiotestAgMember2023-12-310001438569ifrs-full:SubsidiariesWithMaterialNoncontrollingInterestsMember2023-12-310001438569grfs:HaemaagMembergrfs:HaemaagMember2022-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Membergrfs:GrifolsDiagnosticsSolutionsInc.Member2022-12-310001438569grfs:BpcPlasmaIncMembergrfs:BpcPlasmaIncMember2022-12-310001438569grfs:BiotestAgMembergrfs:BiotestAgMember2022-12-310001438569ifrs-full:SubsidiariesWithMaterialNoncontrollingInterestsMember2022-12-310001438569ifrs-full:PlanAssetsMember2023-01-012023-12-310001438569ifrs-full:PlanAssetsMember2022-01-012022-12-310001438569grfs:CanadianBloodServicesMemberifrs-full:NotLaterThanOneYearMember2023-12-310001438569grfs:CanadianBloodServicesMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-12-310001438569grfs:CanadianBloodServicesMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-12-310001438569grfs:CanadianBloodServicesMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2023-12-310001438569grfs:AlbajunaTherapeuticsS.l.Inc.Member2023-10-092023-10-090001438569grfs:SaskatoonPlasmaCenterIncMember2023-07-072023-07-070001438569grfs:PrometicPlasmaResourcesInc.Member2023-07-072023-07-070001438569grfs:PrometicPlasmaResourcesInc.Member2021-12-312021-12-310001438569grfs:GigaGenIncorporationMember2021-03-082021-12-310001438569ifrs-full:ReserveOfCashFlowHedgesMember2023-01-012023-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2023-01-012023-12-310001438569ifrs-full:ReserveOfCashFlowHedgesMember2022-01-012022-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2022-01-012022-12-310001438569ifrs-full:ReserveOfCashFlowHedgesMember2021-01-012021-12-310001438569grfs:MiscellaneousOtherComprehensiveIncomeMember2021-01-012021-12-310001438569currency:USD2023-12-310001438569currency:USD2022-12-310001438569grfs:HaemaagMembergrfs:HaemaagMember2023-01-012023-12-310001438569grfs:BpcPlasmaIncMembergrfs:BpcPlasmaIncMember2023-01-012023-12-310001438569grfs:HaemaagMembergrfs:HaemaagMember2022-01-012022-12-310001438569grfs:BpcPlasmaIncMembergrfs:BpcPlasmaIncMember2022-01-012022-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Membergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:BiotestAgMembergrfs:BiotestAgMember2023-01-012023-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Membergrfs:GrifolsDiagnosticsSolutionsInc.Member2022-01-012022-12-310001438569grfs:BiotestAgMembergrfs:BiotestAgMember2022-01-012022-12-310001438569ifrs-full:LiquidityRiskMember2023-12-310001438569ifrs-full:LiquidityRiskMember2022-12-310001438569grfs:SeniorDebtTrancheBDue2027Membercurrency:USD2023-01-012023-12-310001438569grfs:SeniorDebtTrancheBDue2027Membercurrency:EUR2023-01-012023-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Member2020-05-072020-05-070001438569grfs:GrifolsS.Membergrfs:SeniorUnsecuredNotesMaturingIn2028TwoMembercurrency:USD2023-12-310001438569grfs:GrifolsS.Membergrfs:SeniorUnsecuredNotesMaturingIn2028OneMembercurrency:EUR2023-12-310001438569grfs:GrifolsS.Membergrfs:SeniorUnsecuredNotesMaturing2025Membercurrency:EUR2023-12-310001438569grfs:GrifolsS.Membergrfs:SeniorSecuredNotesMaturingIn2027Membercurrency:EUR2023-12-310001438569grfs:GrifolsS.Membergrfs:SeniorSecuredNotesMaturingIn2025Membercurrency:EUR2023-12-310001438569grfs:OtherNonCurrentLoansMemberifrs-full:BottomOfRangeMember2023-12-310001438569grfs:OtherCurrentLoansMemberifrs-full:BottomOfRangeMember2023-12-310001438569ifrs-full:CurrencySwapContractMemberifrs-full:CashFlowHedgesMembercurrency:USD2022-06-280001438569ifrs-full:CurrencySwapContractMemberifrs-full:CashFlowHedgesMembercurrency:EUR2022-06-280001438569grfs:InstitutoGrifolsS.a.Member2021-12-310001438569ifrs-full:CurrencySwapContractMemberifrs-full:CashFlowHedgesMembercurrency:EUR2021-10-050001438569grfs:SeniorUnsecuredNotesMaturingIn2028TwoMember2021-10-050001438569grfs:SeniorUnsecuredNotesMaturingIn2028OneMember2021-10-050001438569grfs:SeniorDebtTrancheBMaturityNovember2027Membergrfs:IfrsSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBMaturityNovember2027Membergrfs:EuriborMembercurrency:EUR2023-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Membergrfs:IfrsSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembercurrency:USD2023-12-310001438569grfs:OtherNonCurrentLoansMemberifrs-full:TopOfRangeMembergrfs:EuriborMember2023-12-310001438569grfs:OtherCurrentLoansMemberifrs-full:TopOfRangeMembergrfs:EuriborMember2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Membercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBDue2027Membercurrency:EUR2023-12-310001438569ifrs-full:CurrencyRiskMembercurrency:EUR2023-12-310001438569grfs:SeniorUnsecuredNotesUsDollars2021Member2023-12-310001438569grfs:SeniorUnsecuredNotesEuros2021Member2023-12-310001438569grfs:SeniorUnsecuredNotes2017Member2023-12-310001438569grfs:SeniorSecuredNotes2019Member2023-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Member2023-12-310001438569grfs:IfrsSeniorNotesMember2023-12-310001438569ifrs-full:CurrencyRiskMembercurrency:EUR2022-12-310001438569grfs:SeniorUnsecuredNotesUsDollars2021Member2022-12-310001438569grfs:SeniorUnsecuredNotesEuros2021Member2022-12-310001438569grfs:SeniorUnsecuredNotes2017Member2022-12-310001438569grfs:SeniorSecuredNotes2019Member2022-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Member2022-12-310001438569grfs:IfrsSeniorNotesMember2022-12-310001438569grfs:SeniorUnsecuredNotesUsDollars2021Member2021-12-310001438569grfs:SeniorUnsecuredNotesEuros2021Member2021-12-310001438569grfs:SeniorUnsecuredNotes2017Member2021-12-310001438569grfs:SeniorSecuredNotes2019Member2021-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Member2021-12-310001438569grfs:IfrsSeniorNotesMember2021-12-310001438569ifrs-full:UnallocatedAmountsMember2023-12-310001438569ifrs-full:CountryOfDomicileMember2023-12-310001438569grfs:UnitedStatesAndCanadaMember2023-12-310001438569grfs:RestOfWorldMember2023-12-310001438569grfs:EuropeanUnionExcludingSpainMember2023-12-310001438569ifrs-full:UnallocatedAmountsMember2022-12-310001438569ifrs-full:CountryOfDomicileMember2022-12-310001438569grfs:UnitedStatesAndCanadaMember2022-12-310001438569grfs:RestOfWorldMember2022-12-310001438569grfs:EuropeanUnionExcludingSpainMember2022-12-310001438569ifrs-full:UnallocatedAmountsMember2021-12-310001438569ifrs-full:CountryOfDomicileMember2021-12-310001438569grfs:UnitedStatesAndCanadaMember2021-12-310001438569grfs:RestOfWorldMember2021-12-310001438569grfs:EuropeanUnionExcludingSpainMember2021-12-310001438569ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMemberifrs-full:TopOfRangeMember2023-01-012023-12-310001438569ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMemberifrs-full:BottomOfRangeMember2023-01-012023-12-310001438569grfs:CurrentlyMarketedProductsMemberifrs-full:TopOfRangeMember2023-01-012023-12-310001438569grfs:CurrentlyMarketedProductsMemberifrs-full:BottomOfRangeMember2023-01-012023-12-310001438569ifrs-full:ComputerSoftwareMember2023-01-012023-12-310001438569ifrs-full:CapitalisedDevelopmentExpenditureMember2023-01-012023-12-310001438569grfs:TalecrisMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:BiotestAgMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CustomerrelatedIntangibleAssetsMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherIntangibleAssetsMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CapitalisedDevelopmentExpenditureMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2023-01-012023-12-310001438569grfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2023-01-012023-12-310001438569grfs:TalecrisMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569grfs:ProgenikaBiopharmaSaMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569grfs:BiotestAgMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CustomerrelatedIntangibleAssetsMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:OtherIntangibleAssetsMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CapitalisedDevelopmentExpenditureMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:OtherSegmentsMember2023-01-012023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:DiagnosticMember2023-01-012023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BioSuppliesMember2023-01-012023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BiopharmaMember2023-01-012023-12-310001438569ifrs-full:UnallocatedAmountsMember2023-01-012023-12-310001438569ifrs-full:OperatingSegmentsMember2023-01-012023-12-310001438569grfs:UnitedStatesAndCanadaMember2023-01-012023-12-310001438569grfs:RestOfWorldMember2023-01-012023-12-310001438569grfs:EuropeanUnionExcludingSpainMember2023-01-012023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:OtherSegmentsMember2022-01-012022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:DiagnosticMember2022-01-012022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BioSuppliesMember2022-01-012022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BiopharmaMember2022-01-012022-12-310001438569ifrs-full:UnallocatedAmountsMember2022-01-012022-12-310001438569ifrs-full:OperatingSegmentsMember2022-01-012022-12-310001438569ifrs-full:CountryOfDomicileMember2022-01-012022-12-310001438569grfs:UnitedStatesAndCanadaMember2022-01-012022-12-310001438569grfs:RestOfWorldMember2022-01-012022-12-310001438569grfs:EuropeanUnionExcludingSpainMember2022-01-012022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:OtherSegmentsMember2021-01-012021-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:DiagnosticMember2021-01-012021-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BioSuppliesMember2021-01-012021-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BiopharmaMember2021-01-012021-12-310001438569ifrs-full:UnallocatedAmountsMember2021-01-012021-12-310001438569ifrs-full:OperatingSegmentsMember2021-01-012021-12-310001438569ifrs-full:CountryOfDomicileMember2021-01-012021-12-310001438569grfs:UnitedStatesAndCanadaMember2021-01-012021-12-310001438569grfs:RestOfWorldMember2021-01-012021-12-310001438569grfs:EuropeanUnionExcludingSpainMember2021-01-012021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CapitalisedDevelopmentExpenditureMember2023-01-012023-12-310001438569grfs:HaemaPlasmaKftMember2022-01-012022-12-310001438569grfs:GrifolsBiotestHoldingsGmbhBiotestAgMember2022-01-012022-12-310001438569grfs:AccessBiologicalsLLCMember2022-01-012022-12-310001438569ifrs-full:PresentValueOfDefinedBenefitObligationMember2023-01-012023-12-310001438569ifrs-full:PresentValueOfDefinedBenefitObligationMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:PlantAndMachineryMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:PlantAndMachineryMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMembergrfs:PlantAndMachineryMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMembergrfs:PlantAndMachineryMember2022-01-012022-12-310001438569grfs:BiotestAgMemberifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2022-01-012022-12-310001438569grfs:AccessBiologicalsLlcMemberifrs-full:GrossCarryingAmountMemberifrs-full:CustomerrelatedIntangibleAssetsMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:OtherIntangibleAssetsMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-01-012022-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:CapitalisedDevelopmentExpenditureMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2022-01-012022-12-310001438569grfs:CurrentlyMarketedProductsAndCustomerRelatedIntangibleAssetsMember2022-01-012022-12-310001438569grfs:BiotestAgMember2022-04-252022-04-250001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2023-10-090001438569grfs:GrifolsUkLtdMembergrfs:BiotestUkLtdMember2023-06-010001438569grfs:AlbajunaTherapeuticsS.l.Inc.Member2022-10-090001438569grfs:AccessBiologicalLLCMember2022-06-150001438569grfs:AlbimmuneS.l.Member2022-01-130001438569grfs:GrifolsCanadaPlasmaIncMember2021-12-310001438569grfs:TianchengGermanyPharmaceuticalHoldingsMember2021-10-050001438569grfs:GrifolsEscrowIssuerS.aMember2021-08-260001438569grfs:GigagenIncMember2021-03-080001438569grfs:StockOptionsMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:StockOptionsMembergrfs:CashSettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:RestrictedShareUnitRetentionPlanMember2023-01-012023-12-310001438569grfs:ClassAndClassBSharesMemberifrs-full:TreasurySharesMember2023-12-310001438569grfs:ClassAndClassBSharesMemberifrs-full:TreasurySharesMember2022-12-310001438569ifrs-full:GrossCarryingAmountMember2023-12-310001438569ifrs-full:GrossCarryingAmountMember2022-12-310001438569grfs:BiotestAgMembergrfs:GrifolsDiagnosticsSolutionsIncMember2022-04-250001438569grfs:SaskatoonPlasmaCenterIncMember2023-07-070001438569grfs:HaierGroupCorporationMember2023-01-012023-12-310001438569grfs:GrifolsEgyptMember2021-07-292021-07-290001438569ifrs-full:OrdinarySharesMembergrfs:CashSettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:BasqueCountrySpainMember2023-01-012023-12-310001438569country:US2023-01-012023-12-310001438569grfs:AraclonBiotechS.lMember2021-10-012021-10-310001438569grfs:IFRSIPOMember2006-05-170001438569grfs:CrbInverbioMembergrfs:MecwinsS.aMember2018-10-220001438569grfs:MecwinsS.aMember2018-10-220001438569grfs:RestrictedShareUnitRetentionPlanMember2022-12-310001438569grfs:RestrictedStockUnitsSettledBy28022025Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-12-310001438569grfs:RestrictedStockUnitsSettledBy28022024Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-12-310001438569grfs:RestrictedStockUnitsSettledBy22022025Membergrfs:EquitySettledShareBasedPaymentPlanMember2023-12-310001438569grfs:RestrictedStockUnitsSettledBy2027Membergrfs:CashSettledShareBasedPaymentPlanMember2023-12-310001438569grfs:RestrictedStockUnitsSettledBy2025Membergrfs:CashSettledShareBasedPaymentPlanMember2023-12-310001438569grfs:HaierGroupCorporationMembergrfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-292023-12-290001438569grfs:SpanishCompaniesOtherThanParentMember2023-12-310001438569grfs:SpanishCompaniesOtherThanParentMember2022-12-310001438569grfs:GicSovereignWealthFundOfSingaporeMembergrfs:BiomatUsaGroupMember2023-12-310001438569grfs:GicSovereignWealthFundOfSingaporeMember2021-12-310001438569ifrs-full:TopOfRangeMembergrfs:BiotestAgMember2023-01-012023-12-310001438569ifrs-full:BottomOfRangeMembergrfs:BiotestAgMember2023-01-012023-12-310001438569grfs:GigagenIncMember2023-01-012023-12-310001438569grfs:GigagenIncMember2022-01-012022-12-310001438569grfs:KiroGrifolsMember2023-01-012023-12-310001438569grfs:BioSuppliesMember2023-01-012023-12-310001438569grfs:BiopharmaMember2023-01-012023-12-310001438569grfs:KiroGrifolsMember2022-01-012022-12-310001438569grfs:DiagnosticMember2022-01-012022-12-310001438569grfs:BioSuppliesMember2022-01-012022-12-310001438569grfs:BiopharmaMember2022-01-012022-12-310001438569ifrs-full:NotLaterThanOneYearMember2023-12-310001438569ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-12-310001438569ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-12-310001438569ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2023-12-310001438569ifrs-full:TopOfRangeMember2021-01-012021-12-310001438569ifrs-full:BottomOfRangeMember2021-01-012021-12-310001438569grfs:KedplasmaLlcMember2021-03-310001438569grfs:BiotekAmericaLlcMember2023-01-012023-12-310001438569grfs:BiotekAmericaLlcMember2022-01-012022-12-310001438569grfs:SevenPlasmaCentersAcquiredApril22024Memberifrs-full:MajorBusinessCombinationMembergrfs:GrifolsBioNorthAmericaLlcMember2024-04-020001438569grfs:SquadronReinsuranceDesignatedActivityCompanyMember2023-12-310001438569grfs:PlazmaszolglatKftMember2023-12-310001438569grfs:PlasmavitaHealthcareIiGmbhMember2023-12-310001438569grfs:PlasmavitaHealthcareGmbhMember2023-12-310001438569grfs:PlasmaServiceEuropeGmbhMember2023-12-310001438569grfs:MedionGrifolsDiagnosticAgMember2023-12-310001438569grfs:MedcomAdvanceMember2023-12-310001438569grfs:MecwinsS.l.Member2023-12-310001438569grfs:GrifolsWorldwideOperationsUsaIncorporationMember2023-12-310001438569grfs:GrifolsUsaLimitedLiabilityCompanyMember2023-12-310001438569grfs:GrifolsTherapeuticsLLCMember2023-12-310001438569grfs:GrifolsThailandLimitedMember2023-12-310001438569grfs:GrifolsPyrenessResearchCenterS.l.Member2023-12-310001438569grfs:GrifolsMalaysiaSdnBhdMember2023-12-310001438569grfs:GrifolsLaboratorySolutionsIncMember2023-12-310001438569grfs:GrifolsInnovationAndNewTechnologiesLimitedMember2023-12-310001438569grfs:GrifolsH.k.LimitedMember2023-12-310001438569grfs:GrifolsDiagnosticsSolutionsIncorporationMember2023-12-310001438569grfs:GrifolsCanadaPlasmaOntarioInc.Member2023-12-310001438569grfs:GrifolsCanadaPlasmaInc.Member2023-12-310001438569grfs:GrifolsBioSuppliesInc.Member2023-12-310001438569grfs:GrifolsBioNorthAmericaLlcMember2023-12-310001438569grfs:GrifolsBiologicalsLLCMember2023-12-310001438569grfs:GigaGenIncorporationMember2023-12-310001438569grfs:DiagnosticGrifolsS.a.Member2023-12-310001438569grfs:CaraPlasmaS.r.o.Member2023-12-310001438569grfs:BiotestSchweizAgMember2023-12-310001438569grfs:BiotestPharmaGmbhMember2023-12-310001438569grfs:BiotestPharmaceuticalsIlaPazarlamaAnonimSirketiMember2023-12-310001438569grfs:BiotestLuxS.a.r.l.Member2023-12-310001438569grfs:BiotestHungariaKftMember2023-12-310001438569grfs:BiotestHellasM.e.p.e.Member2023-12-310001438569grfs:BiotestGrundstcksverwaltungsGmbhMember2023-12-310001438569grfs:BiotestAustriaGmbhMember2023-12-310001438569grfs:BiomatUsaIncorporationMember2023-12-310001438569grfs:BiomatNewcoCorp.Member2023-12-310001438569grfs:BiomatHoldingsLlcMember2023-12-310001438569grfs:BiomatHoldcoLlc.Member2023-12-310001438569grfs:BiodarouPlcMember2023-12-310001438569grfs:AraclonBiotechS.l.Member2023-12-310001438569grfs:AlkahestIncMember2023-12-310001438569grfs:AlbimmuneS.l.Member2023-12-310001438569grfs:SquadronReinsuranceDesignatedActivityCompanyMember2022-12-310001438569grfs:PlazmaszolglatKftMember2022-12-310001438569grfs:PlasmavitaHealthcareIiGmbhMember2022-12-310001438569grfs:PlasmavitaHealthcareGmbhMember2022-12-310001438569grfs:PlasmaServiceEuropeGmbhMember2022-12-310001438569grfs:MedionGrifolsDiagnosticAgMember2022-12-310001438569grfs:MedcomAdvanceMember2022-12-310001438569grfs:MecwinsS.l.Member2022-12-310001438569grfs:GrifolsWorldwideOperationsUsaIncorporationMember2022-12-310001438569grfs:GrifolsUsaLimitedLiabilityCompanyMember2022-12-310001438569grfs:GrifolsTherapeuticsLLCMember2022-12-310001438569grfs:GrifolsThailandLimitedMember2022-12-310001438569grfs:GrifolsPyrenessResearchCenterS.l.Member2022-12-310001438569grfs:GrifolsMalaysiaSdnBhdMember2022-12-310001438569grfs:GrifolsLaboratorySolutionsIncMember2022-12-310001438569grfs:GrifolsInnovationAndNewTechnologiesLimitedMember2022-12-310001438569grfs:GrifolsH.k.LimitedMember2022-12-310001438569grfs:GrifolsDiagnosticsSolutionsIncorporationMember2022-12-310001438569grfs:GrifolsCanadaPlasmaInc.Member2022-12-310001438569grfs:GrifolsBioSuppliesInc.Member2022-12-310001438569grfs:GrifolsBioNorthAmericaLlcMember2022-12-310001438569grfs:GrifolsBiologicalsLLCMember2022-12-310001438569grfs:GoetechLlcDBMedkeeperMember2022-12-310001438569grfs:GigaGenIncorporationMember2022-12-310001438569grfs:DiagnosticGrifolsS.a.Member2022-12-310001438569grfs:ChiquitoAcquisitionCorporationMember2022-12-310001438569grfs:CaraPlasmaS.r.o.Member2022-12-310001438569grfs:BiotestUkLtd.Member2022-12-310001438569grfs:BiotestSchweizAgMember2022-12-310001438569grfs:BiotestPharmaGmbhMember2022-12-310001438569grfs:BiotestPharmaceuticalsIlaPazarlamaAnonimSirketiMember2022-12-310001438569grfs:BiotestMedicalS.l.u.Member2022-12-310001438569grfs:BiotestItaliaS.r.l.Member2022-12-310001438569grfs:BiotestHungariaKftMember2022-12-310001438569grfs:BiotestHellasM.e.p.e.Member2022-12-310001438569grfs:BiotestGrundstcksverwaltungsGmbhMember2022-12-310001438569grfs:BiotestFranceSasMember2022-12-310001438569grfs:BiotestFarmacuticaLtdaMember2022-12-310001438569grfs:BiotestAustriaGmbhMember2022-12-310001438569grfs:BiomatUsaIncorporationMember2022-12-310001438569grfs:BiomatNewcoCorp.Member2022-12-310001438569grfs:BiomatHoldcoLlc.Member2022-12-310001438569grfs:BiodarouPlcMember2022-12-310001438569grfs:AraclonBiotechS.l.Member2022-12-310001438569grfs:AlkahestIncMember2022-12-310001438569grfs:AlbimmuneS.l.Member2022-12-310001438569grfs:AlbajunaTherapeuticsS.lOneMember2022-12-310001438569grfs:AlbajunaTherapeuticsS.lMember2022-12-310001438569grfs:AccessPlasmaLlcCorpMember2022-12-310001438569grfs:AccessCellCultureLlcMember2022-12-310001438569grfs:AccessBiologicalsLlcMember2022-12-310001438569grfs:AccessBiologicalsIcDiscIncMember2022-12-310001438569grfs:VcnBioscienceS.l.Member2021-12-310001438569grfs:TalecrisPlasmaResourcesIncorporationMember2021-12-310001438569grfs:SquadronReinsuranceDesignatedActivityCompanyMember2021-12-310001438569grfs:SingulexIncorporationMember2021-12-310001438569grfs:PlasmavitaHealthcareIiGmbhMember2021-12-310001438569grfs:PlasmavitaHealthcareGmbhMember2021-12-310001438569grfs:MedionGrifolsDiagnosticAgMember2021-12-310001438569grfs:MedcomAdvanceMember2021-12-310001438569grfs:MecwinsS.l.Member2021-12-310001438569grfs:GrifolsWorldwideOperationsUsaIncorporationMember2021-12-310001438569grfs:GrifolsUsaLimitedLiabilityCompanyMember2021-12-310001438569grfs:GrifolsTherapeuticsLLCMember2021-12-310001438569grfs:GrifolsThailandLimitedMember2021-12-310001438569grfs:GrifolsPyrenessResearchCenterS.l.Member2021-12-310001438569grfs:GrifolsMalaysiaSdnBhdMember2021-12-310001438569grfs:GrifolsLaboratorySolutionsIncMember2021-12-310001438569grfs:GrifolsInnovationAndNewTechnologiesLimitedMember2021-12-310001438569grfs:GrifolsH.k.LimitedMember2021-12-310001438569grfs:GrifolsDiagnosticsSolutionsIncorporationMember2021-12-310001438569grfs:GrifolsCanadaLimitedMember2021-12-310001438569grfs:GrifolsBioSuppliesInc.Member2021-12-310001438569grfs:GrifolsBioNorthAmericaLlcMember2021-12-310001438569grfs:GrifolsBiologicalsLLCMember2021-12-310001438569grfs:GoetechLlcDBMedkeeperMember2021-12-310001438569grfs:GigaGenIncorporationMember2021-12-310001438569grfs:DiagnosticGrifolsS.a.Member2021-12-310001438569grfs:ChiquitoAcquisitionCorporationMember2021-12-310001438569grfs:BiomatUsaIncorporationMember2021-12-310001438569grfs:BiomatNewcoCorp.Member2021-12-310001438569grfs:BiomatHoldcoLlc.Member2021-12-310001438569grfs:AradigmCorporationMember2021-12-310001438569grfs:AraclonBiotechS.l.Member2021-12-310001438569grfs:AlkahestIncMember2021-12-310001438569grfs:AlbajunaTherapeuticsS.lOneMember2021-12-310001438569grfs:AlbajunaTherapeuticsS.lMember2021-12-310001438569grfs:AccessPlasmaLlcCorpMember2021-12-310001438569grfs:AccessPlasmaLlcCorpMember2021-12-310001438569grfs:AccessCellCultureLlcMember2021-12-310001438569grfs:AccessCellCultureLlcMember2021-12-310001438569grfs:AccessBiologicalsLlcMember2021-12-310001438569grfs:AccessBiologicalsLlcMember2021-12-310001438569grfs:AccessBiologicalsIcDiscIncMember2021-12-310001438569grfs:AccessBiologicalsIcDiscIncMember2021-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Member2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticsSolutionsIncMember2019-03-310001438569grfs:ProgenikaBiopharmaS.a.Member2023-12-310001438569grfs:LaboratoriosGrifolsS.a.Member2023-12-310001438569grfs:KiroGrifolsS.LMember2023-12-310001438569grfs:InstitutoGrifolsS.a.Member2023-12-310001438569grfs:GrifolsWorldwideOperationsLimitedMember2023-12-310001438569grfs:GrifolsViajesS.a.Member2023-12-310001438569grfs:GrifolsUkLimitedMember2023-12-310001438569grfs:GrifolsSharedServicesNorthAmericaIncorporationMember2023-12-310001438569grfs:GrifolsS.r.o.Member2023-12-310001438569grfs:GrifolsPortugalProductosFarmaceuticosEHospitalaresLda.Member2023-12-310001438569grfs:GrifolsPolskaSp.z.o.o.Member2023-12-310001438569grfs:GrifolsPharmaceuticalTechnologyShanghaiCo.LimitedMember2023-12-310001438569grfs:GrifolsNordicAbMember2023-12-310001438569grfs:GrifolsMovacoS.a.Member2023-12-310001438569grfs:GrifolsMiddleEastAfricaLlcMember2023-12-310001438569grfs:GrifolsMexicoS.a.DeC.v.Member2023-12-310001438569grfs:GrifolsKoreaCo.LtdMember2023-12-310001438569grfs:GrifolsJapanK.k.Member2023-12-310001438569grfs:GrifolsItaliaS.p.aMember2023-12-310001438569grfs:GrifolsInternationalS.a.Member2023-12-310001438569grfs:GrifolsIndiaHealthcarePrivateLimitedMember2023-12-310001438569grfs:GrifolsFranceS.a.r.l.Member2023-12-310001438569grfs:GrifolsEngineeringS.a.Member2023-12-310001438569grfs:GrifolsEgyptForPlasmaDerivativesS.a.e.Member2023-12-310001438569grfs:GrifolsDiagnosticsEquipmentTaiwanLimitedMember2023-12-310001438569grfs:GrifolsDeutschlandGmbhMember2023-12-310001438569grfs:GrifolsColombiaLimitedLiabilityCompanyMember2023-12-310001438569grfs:GrifolsChileS.a.Member2023-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2023-12-310001438569grfs:GrifolsCanadaLimitedMember2023-12-310001438569grfs:GrifolsBrasilLda.Member2023-12-310001438569grfs:GrifolsBiotestHoldingsGmbhMember2023-12-310001438569grfs:GrifolsAustraliaPrivateLimitedMember2023-12-310001438569grfs:GrifolsAsiaPacificPrivateLimitedMember2023-12-310001438569grfs:GrifolsArgentinaS.a.Member2023-12-310001438569grfs:BiotestMedicalS.l.u.Member2023-12-310001438569grfs:BiotestItaliaS.r.l.Member2023-12-310001438569grfs:BiotestFranceSasMember2023-12-310001438569grfs:BiotestFarmacuticaLtdaMember2023-12-310001438569grfs:BiotestAgMember2023-12-310001438569grfs:BiomatS.a.Member2023-12-310001438569grfs:AlbajunaTherapeuticsS.lOneMember2023-12-310001438569grfs:AiguesMineralsDeVilajuigaS.A.Member2023-12-310001438569grfs:ProgenikaBiopharmaS.a.Member2022-12-310001438569grfs:LaboratoriosGrifolsS.a.Member2022-12-310001438569grfs:KiroGrifolsS.LMember2022-12-310001438569grfs:InstitutoGrifolsS.a.Member2022-12-310001438569grfs:GripdanInvestS.lMember2022-12-310001438569grfs:GrifolsWorldwideOperationsLimitedMember2022-12-310001438569grfs:GrifolsViajesS.a.Member2022-12-310001438569grfs:GrifolsUkLimitedMember2022-12-310001438569grfs:GrifolsSharedServicesNorthAmericaIncorporationMember2022-12-310001438569grfs:GrifolsS.r.o.Member2022-12-310001438569grfs:GrifolsPortugalProductosFarmaceuticosEHospitalaresLda.Member2022-12-310001438569grfs:GrifolsPolskaSp.z.o.o.Member2022-12-310001438569grfs:GrifolsPharmaceuticalTechnologyShanghaiCo.LimitedMember2022-12-310001438569grfs:GrifolsNordicAbMember2022-12-310001438569grfs:GrifolsMovacoS.a.Member2022-12-310001438569grfs:GrifolsMiddleEastAfricaLlcMember2022-12-310001438569grfs:GrifolsMexicoS.a.DeC.v.Member2022-12-310001438569grfs:GrifolsKoreaCo.LtdMember2022-12-310001438569grfs:GrifolsJapanK.k.Member2022-12-310001438569grfs:GrifolsItaliaS.p.aMember2022-12-310001438569grfs:GrifolsInternationalS.a.Member2022-12-310001438569grfs:GrifolsIndiaHealthcarePrivateLimitedMember2022-12-310001438569grfs:GrifolsFranceS.a.r.l.Member2022-12-310001438569grfs:GrifolsEscrowIssuerS.a.Member2022-12-310001438569grfs:GrifolsEngineeringS.a.Member2022-12-310001438569grfs:GrifolsEgyptForPlasmaDerivativesS.a.e.Member2022-12-310001438569grfs:GrifolsDiagnosticsEquipmentTaiwanLimitedMember2022-12-310001438569grfs:GrifolsDeutschlandGmbhMember2022-12-310001438569grfs:GrifolsColombiaLimitedLiabilityCompanyMember2022-12-310001438569grfs:GrifolsChileS.a.Member2022-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2022-12-310001438569grfs:GrifolsCanadaLimitedMember2022-12-310001438569grfs:GrifolsBrasilLda.Member2022-12-310001438569grfs:GrifolsBiotestHoldingsGmbhMember2022-12-310001438569grfs:GrifolsAustraliaPrivateLimitedMember2022-12-310001438569grfs:GrifolsAsiaPacificPrivateLimitedMember2022-12-310001438569grfs:GrifolsArgentinaS.a.Member2022-12-310001438569grfs:BiotestAgMember2022-12-310001438569grfs:BiomatS.a.Member2022-12-310001438569grfs:AiguesMineralsDeVilajuigaS.A.Member2022-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2021-12-310001438569grfs:ProgenikaBiopharmaS.a.Member2021-12-310001438569grfs:LogisticaGrifolsS.a.DeC.v.MergedWithGrifolsMexicoS.a.DeC.v.Member2021-12-310001438569grfs:LaboratoriosGrifolsS.a.Member2021-12-310001438569grfs:KiroGrifolsS.LMember2021-12-310001438569grfs:InstitutoGrifolsS.a.Member2021-12-310001438569grfs:GripdanInvestS.lMember2021-12-310001438569grfs:GrifolsWorldwideOperationsLimitedMember2021-12-310001438569grfs:GrifolsViajesS.a.Member2021-12-310001438569grfs:GrifolsUkLimitedMember2021-12-310001438569grfs:GrifolsSharedServicesNorthAmericaIncorporationMember2021-12-310001438569grfs:GrifolsS.r.o.Member2021-12-310001438569grfs:GrifolsPortugalProductosFarmaceuticosEHospitalaresLda.Member2021-12-310001438569grfs:GrifolsPolskaSp.z.o.o.Member2021-12-310001438569grfs:GrifolsPharmaceuticalTechnologyShanghaiCo.LimitedMember2021-12-310001438569grfs:GrifolsNordicAbMember2021-12-310001438569grfs:GrifolsMovacoS.a.Member2021-12-310001438569grfs:GrifolsMiddleEastAfricaLlcMember2021-12-310001438569grfs:GrifolsMexicoS.a.DeC.v.Member2021-12-310001438569grfs:GrifolsKoreaCo.LtdMember2021-12-310001438569grfs:GrifolsJapanK.k.Member2021-12-310001438569grfs:GrifolsItaliaS.p.aMember2021-12-310001438569grfs:GrifolsInternationalS.a.Member2021-12-310001438569grfs:GrifolsIndiaHealthcarePrivateLimitedMember2021-12-310001438569grfs:GrifolsFranceS.a.r.l.Member2021-12-310001438569grfs:GrifolsEscrowIssuerS.a.Member2021-12-310001438569grfs:GrifolsEngineeringS.a.Member2021-12-310001438569grfs:GrifolsEgyptForPlasmaDerivativesS.a.e.Member2021-12-310001438569grfs:GrifolsDiagnosticsEquipmentTaiwanLimitedMember2021-12-310001438569grfs:GrifolsDeutschlandGmbhMember2021-12-310001438569grfs:GrifolsColombiaLimitedLiabilityCompanyMember2021-12-310001438569grfs:GrifolsChileS.a.Member2021-12-310001438569grfs:GrifolsCanadaTherapeuticsIncFormerlyGreenCrossBiotherapeuticsInc.CanadaMember2021-12-310001438569grfs:GrifolsCanadaPlasmaInc.Member2021-12-310001438569grfs:GrifolsBrasilLda.Member2021-12-310001438569grfs:GrifolsAustraliaPrivateLimitedMember2021-12-310001438569grfs:GrifolsAsiaPacificPrivateLimitedMember2021-12-310001438569grfs:GrifolsArgentinaS.a.Member2021-12-310001438569grfs:BiotekAmericaLlcMember2021-12-310001438569grfs:BiomatS.a.Member2021-12-310001438569grfs:AiguesMineralsDeVilajuigaS.A.Member2021-12-310001438569grfs:BiotestAgMemberifrs-full:PreferenceSharesMembergrfs:GrifolsDiagnosticsSolutionsIncMember2022-04-250001438569grfs:BiotestAgMemberifrs-full:OrdinarySharesMembergrfs:GrifolsDiagnosticsSolutionsIncMember2022-04-250001438569grfs:BiotestAgMemberifrs-full:PreferenceSharesMember2022-04-250001438569grfs:BiotestAgMemberifrs-full:OrdinarySharesMember2022-04-250001438569ifrs-full:PreferenceSharesMember2012-07-2300014385692012-07-220001438569ifrs-full:PreferenceSharesMember2022-12-310001438569grfs:HaemaGAndBPCPlasmaIncMember2018-12-012018-12-310001438569grfs:UnusedTaxLossesThatWillBeRecoveredInLessThanFiveYearsMember2023-01-012023-12-310001438569grfs:BiotestAgMember2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticsSolutionsInc.Member2022-12-310001438569ifrs-full:FixedInterestRateMemberifrs-full:InterestRateRiskMember2023-01-012023-12-310001438569ifrs-full:CurrencyRiskMembercurrency:EUR2023-01-012023-12-310001438569ifrs-full:FloatingInterestRateMember2023-01-012023-12-310001438569ifrs-full:FixedInterestRateMemberifrs-full:InterestRateRiskMember2022-01-012022-12-310001438569ifrs-full:CurrencyRiskMembercurrency:EUR2022-01-012022-12-310001438569ifrs-full:FloatingInterestRateMember2022-01-012022-12-310001438569grfs:NatSalesSensitivityScenarioMember2023-01-012023-12-310001438569grfs:BloodTypingSolutionsSalesSensitivityScenarioMember2023-01-012023-12-310001438569ifrs-full:SeparateMember2023-12-310001438569ifrs-full:SeparateMember2022-12-310001438569grfs:TianchengGermanyPharmaceuticalHoldingsMembergrfs:BiotestAgMember2021-10-052021-10-050001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-290001438569grfs:BiotekAmericaLlcMember2023-12-310001438569grfs:HaierGroupCorporationMembergrfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticSolutionsInc.Member2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticSolutionsInc.Member2023-12-290001438569grfs:ClinicalDiagnosticsSalesSensitivityScenarioMember2023-01-012023-12-310001438569grfs:DiagnosticMembergrfs:ClinicalDiagnosticsSalesSensitivityScenarioMember2022-01-012022-12-310001438569grfs:DiagnosticMember2023-01-012023-12-310001438569grfs:KiroGrifolsS.LMember2023-07-272023-07-270001438569grfs:UnsecuredLongTermLoanMember2023-12-310001438569grfs:UnsecuredLongTermLoanMember2022-12-310001438569grfs:DistributorCommissionLiabilitiesMember2023-12-310001438569grfs:DistributorCommissionLiabilitiesMember2022-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-01-012023-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-12-310001438569ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-01-012021-12-310001438569ifrs-full:AmountRecognisedInOtherComprehensiveIncomeAndAccumulatedInEquityRelatingToNoncurrentAssetsOrDisposalGroupsHeldForSaleMember2023-01-012023-12-310001438569grfs:AccessBiologicalsLlcMember2017-01-122017-01-120001438569ifrs-full:TreasurySharesMember2023-01-012023-12-310001438569ifrs-full:TreasurySharesMember2022-01-012022-12-310001438569ifrs-full:EquityAttributableToOwnersOfParentMember2022-01-012022-12-310001438569ifrs-full:TreasurySharesMember2021-01-012021-12-310001438569grfs:SeniorDebtTrancheBDue2027Member2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticsSolutionsIncMember2019-03-012019-03-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticsSolutionsIncMember2019-01-012019-12-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMembergrfs:RestrictedShareUnitRetentionPlanMember2023-10-012023-10-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMembergrfs:RestrictedShareUnitRetentionPlanMember2023-05-012023-05-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMembergrfs:RestrictedShareUnitRetentionPlanMember2023-03-012023-03-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMembergrfs:RestrictedShareUnitRetentionPlanMember2022-03-012022-03-310001438569grfs:BiotestAgMemberifrs-full:PreferenceSharesMembergrfs:GrifolsDiagnosticsSolutionsIncMember2022-04-252022-04-250001438569grfs:BiotestAgMemberifrs-full:OrdinarySharesMembergrfs:GrifolsDiagnosticsSolutionsIncMember2022-04-252022-04-250001438569grfs:BiotestAgMemberifrs-full:PreferenceSharesMember2022-04-252022-04-250001438569grfs:BiotestAgMemberifrs-full:OrdinarySharesMember2022-04-252022-04-250001438569grfs:BiotestAgMember2023-12-310001438569grfs:KedplasmaLlcMember2021-03-312021-03-310001438569grfs:ImmunotekBioCentersLlcMember2023-12-310001438569grfs:ImmunotekBioCentersLlcMember2022-12-310001438569grfs:BiotekAmericaLlcMembergrfs:BiotekAmericaLlcMember2021-07-310001438569grfs:GrifolsEgyptMember2021-07-290001438569grfs:ImmunotekBioCentersLlcMembersrt:ScenarioForecastMember2026-01-012026-01-310001438569grfs:ImmunotekBioCentersLlcMembersrt:ScenarioForecastMember2025-01-012025-01-310001438569grfs:ImmunotekBioCentersLlcMembersrt:ScenarioForecastMember2024-07-012024-07-310001438569grfs:ImmunotekBioCentersLlcMembersrt:ScenarioForecastMember2024-04-012024-04-300001438569grfs:ImmunotekBioCentersLlcMember2021-07-012021-07-310001438569grfs:SevenPlasmaCentersAcquiredApril22024Memberifrs-full:MajorBusinessCombinationMember2024-04-022024-04-020001438569grfs:BiotestAgMember2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2019-03-012019-03-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2019-01-012019-12-3100014385692021-10-052021-10-050001438569grfs:GrifolsThailandLtdMember2023-01-012023-12-310001438569grfs:BiomatUsaGroupMember2021-06-300001438569grfs:BiomatNewcoCorp.Member2021-06-3000014385692021-10-050001438569grfs:RevolvingCreditFacilityDueNovember2025Membercurrency:USD2022-12-310001438569grfs:IfrsRevolvingCreditFacilityMember2022-12-3100014385692022-06-150001438569ifrs-full:NoncontrollingInterestsMembergrfs:VcnBioscienceSlMember2022-01-012022-12-310001438569ifrs-full:CurrencySwapContractMemberifrs-full:CashFlowHedgesMembercurrency:USD2021-10-052021-10-050001438569ifrs-full:AssociatesMember2023-12-310001438569ifrs-full:AssociatesMember2022-12-310001438569srt:DirectorMember2023-01-012023-12-310001438569ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2023-01-012023-12-310001438569srt:DirectorMember2022-01-012022-12-310001438569ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2022-01-012022-12-310001438569ifrs-full:JointVenturesWhereEntityIsVenturerMember2022-01-012022-12-310001438569srt:DirectorMember2021-01-012021-12-310001438569ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2021-01-012021-12-310001438569grfs:GrifolsDiagnosticsSolutionsInc.Member2023-12-310001438569grfs:GrifolsDiagnosticSolutionsInc.Member2023-01-012023-12-310001438569grfs:StockOptionsMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-05-310001438569ifrs-full:TopOfRangeMembergrfs:RestrictedShareUnitRetentionPlanMember2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2022-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Membercurrency:USD2023-12-310001438569grfs:IfrsRevolvingCreditFacilityMember2023-12-310001438569grfs:OtherNonCurrentLoansMember2022-12-310001438569grfs:BiotestAgMember2022-04-250001438569grfs:ScrantonPlasmaBVMember2018-12-280001438569srt:DirectorMember2023-12-310001438569ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2023-12-310001438569grfs:InstitutoGrifolsS.a.Member2023-12-310001438569srt:DirectorMember2022-12-310001438569ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2022-12-310001438569grfs:InstitutoGrifolsS.a.Member2022-12-310001438569ifrs-full:NoncurrentAssetsHeldForSaleMembergrfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2020-03-300001438569grfs:GrifolsCanadaPlasmaIncMember2022-01-012022-12-310001438569grfs:GrifolsBioSuppliesIncMember2023-01-012023-12-310001438569grfs:InterstateBloodBankIncorporationMember2022-01-012022-12-310001438569grfs:BiomatUsaIncMember2022-01-012022-12-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMember2023-01-012023-12-310001438569ifrs-full:PreferenceSharesMemberifrs-full:TreasurySharesMember2022-01-012022-12-310001438569grfs:SeniorUnsecuredNotesUsDollars2021Member2023-01-012023-12-310001438569grfs:IfrsSeniorNotesMember2023-01-012023-12-310001438569ifrs-full:AccumulatedImpairmentMember2023-01-012023-12-310001438569ifrs-full:AccumulatedImpairmentMember2022-01-012022-12-310001438569ifrs-full:AccumulatedImpairmentMember2021-01-012021-12-310001438569ifrs-full:EquityAttributableToOwnersOfParentMember2023-01-012023-12-310001438569grfs:BiotestAgMember2022-01-012022-01-010001438569grfs:MecwinsS.aMember2023-01-012023-12-310001438569grfs:TotalOfRestOfEquityAccountedInvesteesMember2022-01-012022-12-310001438569grfs:MecwinsS.aMember2022-01-012022-12-310001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2022-01-012022-12-310001438569grfs:TotalOfRestOfEquityAccountedInvesteesMember2023-01-012023-12-310001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2023-01-012023-12-310001438569grfs:GigaGenIncorporationMember2021-01-012021-12-310001438569grfs:AlbajunaTherapeuticsLimitedLiabilityCompanyMember2021-01-012021-12-310001438569ifrs-full:InterestRateRiskMember2023-01-012023-12-310001438569ifrs-full:InterestRateRiskMember2022-01-012022-12-310001438569ifrs-full:CurrencyRiskMembercurrency:USD2023-12-310001438569ifrs-full:CurrencyRiskMembercurrency:USD2022-12-310001438569grfs:StockOptionsMembergrfs:IfrsShareBasedPaymentArrangementTrancheTwoMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:StockOptionsMembergrfs:IfrsShareBasedPaymentArrangementTrancheOneMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:IfrsRestrictedStockUnitsRsusMembergrfs:IfrsShareBasedPaymentArrangementTrancheTwoMembergrfs:CashSettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:IfrsRestrictedStockUnitsRsusMembergrfs:IfrsShareBasedPaymentArrangementTrancheOneMembergrfs:CashSettledShareBasedPaymentPlanMember2023-05-012023-05-310001438569grfs:RamirezVivarAlfonsoV.GrifolsDiagnosticSolutionsIncMember2022-11-042022-11-040001438569grfs:RevolvingCreditFacilityDueNovember2025Member2020-05-070001438569grfs:RevolvingCreditFacilityDueNovember2025Member2020-05-060001438569ifrs-full:NoncurrentAssetsHeldForSaleMembergrfs:HaierGroupCorporationMembergrfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-290001438569grfs:HaierGroupCorporationMembergrfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-290001438569grfs:LoansAndBorrowingsMember2023-12-310001438569grfs:LoansAndBorrowingsMember2022-12-310001438569grfs:SeniorDebtTrancheBDue2027Member2023-01-012023-12-310001438569grfs:SeniorDebtDue2024Member2023-01-012023-12-310001438569grfs:StockOptionsMemberifrs-full:OrdinarySharesMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-05-310001438569grfs:IfrsRestrictedStockUnitsRsusMemberifrs-full:OrdinarySharesMembergrfs:EquitySettledShareBasedPaymentPlanMember2023-12-310001438569ifrs-full:OtherRelatedPartiesMember2023-12-310001438569ifrs-full:OtherRelatedPartiesMember2022-12-310001438569ifrs-full:LaterThanFiveYearsMember2023-12-310001438569ifrs-full:LaterThanFiveYearsMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2023-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2023-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001438569grfs:DerivativesDesignatedAsHedgingInstrumentsCategoryMember2023-12-310001438569ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2022-12-310001438569ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2022-12-310001438569ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2022-12-310001438569ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2022-12-310001438569grfs:DerivativesDesignatedAsHedgingInstrumentsCategoryMember2022-12-310001438569grfs:ScrantonPlasmaBVMember2023-01-012023-12-310001438569ifrs-full:OtherRelatedPartiesMember2022-01-012022-12-310001438569grfs:ScrantonPlasmaBVMember2022-01-012022-12-310001438569ifrs-full:OtherRelatedPartiesMember2021-01-012021-12-310001438569grfs:ScrantonPlasmaBVMember2021-01-012021-12-310001438569grfs:ScrantonEnterprisesBVMember2023-12-310001438569grfs:RestrictedShareUnitRetentionPlanMember2023-12-310001438569grfs:ImmunotekBioCentersLlcMember2022-01-012022-12-310001438569grfs:EIBLoanMember2015-01-012018-12-310001438569grfs:EIBLoanMember2023-01-012023-12-310001438569ifrs-full:CountryOfDomicileMember2023-01-012023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:NotLaterThanOneYearMember2023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:LaterThanTenYearsMember2023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember2023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMember2023-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:NotLaterThanOneYearMember2022-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:LaterThanTenYearsMember2022-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001438569ifrs-full:PensionDefinedBenefitPlansMemberifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember2022-12-310001438569ifrs-full:PensionDefinedBenefitPlansMember2022-12-310001438569grfs:GigaGenIncorporationMember2021-03-070001438569ifrs-full:OtherRelatedPartiesMember2023-01-012023-12-310001438569ifrs-full:AssociatesMember2023-01-012023-12-310001438569ifrs-full:AssociatesMember2022-01-012022-12-310001438569ifrs-full:AssociatesMember2021-01-012021-12-310001438569ifrs-full:NoncontrollingInterestsMember2021-01-012021-12-310001438569ifrs-full:EquityAttributableToOwnersOfParentMember2021-01-012021-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:MachineryMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:LandAndBuildingsMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerEquipmentMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:MachineryMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LandAndBuildingsMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerEquipmentMember2023-01-012023-12-310001438569ifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:VehiclesMember2022-01-012022-12-310001438569ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerEquipmentMember2022-01-012022-12-310001438569grfs:SevenPlasmaCentersAcquiredApril22024Member2023-01-012023-12-310001438569grfs:SaskatoonPlasmaCenterIncMember2023-01-012023-12-310001438569grfs:HaemaPlasmaKftMember2023-01-012023-12-310001438569grfs:GrifolsCanadaPlasmaIncMember2023-01-012023-12-310001438569grfs:GigaGenIncorporationMember2023-01-012023-12-310001438569grfs:BplPlasmaIncMember2023-01-012023-12-310001438569grfs:BiotestAgMember2023-01-012023-12-310001438569grfs:AlbajunaTherapeuticsS.l.Inc.Member2023-01-012023-12-310001438569grfs:AcquisitionOfPlasmaCentersFromKedplasmaLlcMember2023-01-012023-12-310001438569grfs:AccessBiologicalsLLCMember2023-01-012023-12-310001438569ifrs-full:IssuedCapitalMember2023-01-012023-12-310001438569grfs:GigaGenIncorporationMember2023-01-012023-12-310001438569grfs:GigaGenIncorporationMember2022-01-012022-12-310001438569grfs:DerivativeLiabilitiesMemberifrs-full:CurrencySwapContractMembercurrency:USD2023-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:USD2023-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:JPY2023-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:GBP2023-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:CZK2023-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:CAD2023-12-310001438569grfs:DerivativeAssetsMemberifrs-full:CurrencySwapContractMembercurrency:USD2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:USD2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:TRY2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:MXN2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:EUR2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:CZK2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:CHF2023-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:CAD2023-12-310001438569grfs:DerivativeAssetsMemberifrs-full:CurrencySwapContractMember2023-12-310001438569grfs:DerivativeAssetsMembergrfs:EnergyPowerPurchaseAgreementsMember2023-12-310001438569grfs:DerivativeLiabilitiesMember2023-12-310001438569grfs:DerivativeAssetsMember2023-12-310001438569grfs:DerivativeLiabilitiesMemberifrs-full:CurrencySwapContractMembercurrency:USD2022-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:USD2022-12-310001438569grfs:DerivativeLiabilitiesMembergrfs:ForeignExchangeRateForwardMembercurrency:CAD2022-12-310001438569grfs:DerivativeAssetsMemberifrs-full:CurrencySwapContractMembercurrency:USD2022-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:USD2022-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:GBP2022-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:EUR2022-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:CHF2022-12-310001438569grfs:DerivativeAssetsMembergrfs:ForeignExchangeRateForwardMembercurrency:CAD2022-12-310001438569grfs:DerivativeAssetsMemberifrs-full:CurrencySwapContractMember2022-12-310001438569grfs:DerivativeLiabilitiesMember2022-12-310001438569grfs:DerivativeAssetsMember2022-12-310001438569grfs:FinanceLeaseLiabilitiesMember2023-01-012023-12-310001438569grfs:FinanceLeaseLiabilitiesMember2022-01-012022-12-310001438569grfs:OtherFinancialLiabilitiesMember2021-01-012021-12-310001438569grfs:FinanceLeaseLiabilitiesMember2021-01-012021-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2023-01-012023-12-310001438569grfs:OtherFinancialLiabilitiesMember2023-01-012023-12-310001438569grfs:IfrsBondsMember2023-01-012023-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2022-01-012022-12-310001438569grfs:OtherFinancialLiabilitiesMember2022-01-012022-12-310001438569grfs:IfrsBondsMember2022-01-012022-12-310001438569grfs:SeniorSecuredBankLoansAndOtherLoansMember2021-01-012021-12-310001438569grfs:IfrsBondsMember2021-01-012021-12-310001438569grfs:BiodarourP.j.s.Co.Member2023-01-012023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2022-01-012022-12-310001438569grfs:AccessBiologicalsLlcMember2022-01-012022-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2021-01-012021-12-310001438569grfs:AccessBiologicalsLlcMember2021-01-012021-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Member2023-01-012023-12-310001438569grfs:RevolvingCreditFacilityDueNovember2025Member2022-01-012022-12-310001438569grfs:SevenPlasmaCentersAcquiredApril22024Memberifrs-full:MajorBusinessCombinationMember2024-04-020001438569grfs:AlbajunaTherapeuticsS.l.Inc.Member2023-10-090001438569grfs:PrometicPlasmaResourcesInc.Member2021-12-310001438569grfs:GicSovereignWealthFundOfSingaporeMember2022-12-310001438569grfs:PromissoryNotesMaturingApril2024Member2023-12-310001438569grfs:PromissoryNotesMaturingApril2023Member2022-12-310001438569grfs:SeniorDebtTrancheBMaturityNovember2027Membercurrency:USD2023-12-310001438569grfs:SeniorDebtTrancheBMaturityNovember2027Membercurrency:EUR2023-12-310001438569grfs:EibLoanDueNovember2025Membercurrency:EUR2023-12-310001438569grfs:EibLoanDueDecember2028Membercurrency:EUR2023-12-310001438569grfs:EibLoanDueDecember2025Membercurrency:EUR2023-12-310001438569grfs:SeniorDebtMember2023-12-310001438569grfs:OtherCurrentLoansMember2023-12-310001438569grfs:EIBLoanMember2023-12-310001438569grfs:SeniorDebtTrancheBMaturityNovember2027Membercurrency:USD2022-12-310001438569grfs:SeniorDebtTrancheBMaturityNovember2027Membercurrency:EUR2022-12-310001438569grfs:EibLoanDueNovember2025Membercurrency:EUR2022-12-310001438569grfs:EibLoanDueDecember2028Membercurrency:EUR2022-12-310001438569grfs:EibLoanDueDecember2025Membercurrency:EUR2022-12-310001438569grfs:SeniorDebtMember2022-12-310001438569grfs:OtherCurrentLoansMember2022-12-310001438569grfs:EIBLoanMember2022-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2023-12-310001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2022-12-310001438569grfs:GrifolsEgyptPlasmaDerivativesMember2022-01-012022-12-3100014385692022-04-250001438569grfs:KiroGrifolsS.LMember2023-07-270001438569grfs:HaemaGAndBPCPlasmaIncMember2018-12-310001438569grfs:GoetechLlcMember2022-07-310001438569grfs:VcnBioscienceS.lMember2022-03-100001438569grfs:VcnBioscienceS.lMember2022-03-100001438569grfs:GigagenIncMember2017-07-052017-07-050001438569grfs:ShanghaiRaasBloodProductsCo.LtdMember2020-03-302020-03-3000014385692021-12-3100014385692020-12-310001438569ifrs-full:TopOfRangeMember2023-01-012023-12-310001438569ifrs-full:BottomOfRangeMember2023-01-012023-12-310001438569ifrs-full:TopOfRangeMember2022-01-012022-12-310001438569ifrs-full:BottomOfRangeMember2022-01-012022-12-310001438569grfs:SeniorUnsecuredNotesUsDollars2021Member2022-01-012022-12-310001438569grfs:SeniorUnsecuredNotesEuros2021Member2022-01-012022-12-310001438569grfs:SeniorUnsecuredNotes2017Member2022-01-012022-12-310001438569grfs:SeniorSecuredNotes2019Member2022-01-012022-12-310001438569grfs:IfrsSeniorNotesMember2022-01-012022-12-310001438569grfs:GigaGenIncorporationMember2021-12-310001438569ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember2023-12-310001438569ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2023-12-310001438569ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2023-12-310001438569grfs:NotLaterThanSixMonthsMember2023-12-310001438569ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember2022-12-310001438569ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2022-12-310001438569ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2022-12-310001438569grfs:NotLaterThanSixMonthsMember2022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:OtherSegmentsMember2023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:DiagnosticMember2023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BioSuppliesMember2023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BiopharmaMember2023-12-310001438569ifrs-full:OperatingSegmentsMember2023-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:OtherSegmentsMember2022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:DiagnosticMember2022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BioSuppliesMember2022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BiopharmaMember2022-12-310001438569ifrs-full:OperatingSegmentsMember2022-12-310001438569ifrs-full:EliminationOfIntersegmentAmountsMember2022-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:OtherSegmentsMember2021-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:DiagnosticMember2021-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BioSuppliesMember2021-12-310001438569ifrs-full:OperatingSegmentsMembergrfs:BiopharmaMember2021-12-310001438569ifrs-full:OperatingSegmentsMember2021-12-310001438569ifrs-full:EliminationOfIntersegmentAmountsMember2021-12-310001438569grfs:RamirezVivarAlfonsoV.GrifolsDiagnosticSolutionsIncMember2023-12-310001438569grfs:ImmunotekBioCentersLlcMemberifrs-full:NotLaterThanOneYearMember2023-01-012023-12-310001438569grfs:ImmunotekBioCentersLlcMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-01-012023-12-310001438569grfs:ImmunotekBioCentersLlcMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2023-01-012023-12-310001438569grfs:ImmunotekBioCentersLlcMember2023-01-012023-12-310001438569grfs:IfrsSeniorNotesMember2021-12-022021-12-020001438569grfs:CanadianBloodServicesMember2022-09-300001438569grfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticSolutionsInc.Member2023-12-292023-12-290001438569grfs:HaierGroupCorporationMembergrfs:ShanghaiRaasBloodProductsCo.LtdMembergrfs:GrifolsDiagnosticSolutionsInc.Member2023-01-012023-12-310001438569grfs:ImmunotekBioCentersLlcMember2021-07-310001438569grfs:BiotekAmericaLlcMember